CHARLESTON, S.C., Aug. 24, 2010 (GLOBE NEWSWIRE) -- Since Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB:RMCP) acknowledged the successful completion of its Pilot Run for our new manufacturing design changes to our RevVac Safety Syringe earlier in May, the company has been working closely with a U.S. manufacturer to complete market samples. These new samples sport the company's new label, have only eight parts compared to twelve, have even better performance, and are less expensive to mass manufacture. With the completion of market samples, Revolutions Medical can now finalize negotiations with manufacturers, distributors and begin announcing preliminary sales orders over the coming weeks. As countries all over the world continue to put forward legislation for the committed use of safety syringes, timing could not be better.
